Mavyret (glecaprevir/pibrentasvir) is a prescription drug that’s used to treat hepatitis C. Mavyret can cause side effects that range from mild to serious. Examples ...

Mavyret is an antiviral drug prescribed to treat hepatitis C (HCV). It comes as oral tablets and pellets. Mavyret works by stopping HCV from multiplying, which can cure this condition. Mavyret is a ...

Mavyret (glecaprevir/pibrentasvir) is a prescription brand-name medication. The Food and Drug Administration (FDA) has approved it to treat certain forms of hepatitis ...

Editor's Note: This headline and story have been updated to clarify that the FDA approval was for an expanded indication to treat acute HCV. Glecaprevir, one of the two DAAs in Mavyret, was Discovered ...

The Dosage and Administration section has been revised to state that Mavyret is recommended for 12 weeks in liver or kidney transplant recipients. The Food and Drug Administration (FDA) has approved ...

MAVYRET The FDA has approved Mavyret (glecaprevir and pibrentasvir; AbbVie) for the treatment of all 6 genotypes of hepatitis C virus in children 12 to 17 years old or weighing at least 45kg. The Food ...

Get set for even more competition in the hepatitis C space. AbbVie’s Mavyret picked up FDA approval on Thursday as an 8-week treatment regardless of genotype, becoming the first such drug with the ...

AbbVie’s hepatitis C blockbuster Mavyret could soon also be an eight-week treatment for patients with compensated cirrhosis, thanks to positive new phase 3b data. That would give it more firepower as ...

AbbVie Inc. (NYSE:ABBV) is one of the 12 best healthcare stocks to buy now. On June 12, the US Food and Drug Administration (FDA) approved the company’s Mavyret treatment label expansion. The approval ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...